4 Top Stocks With Rs 500-1,000 Crore Revenue to Watch for Future Multibagger Potential: CarTrade Tech, Vijaya Diagnostic, CARE Ratings and ICRA

Stocks with Rs 500-1,000 crore revenue to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. CarTrade Tech, Vijaya Diagnostic, CARE Ratings and ICRA meet that test, with market caps from Rs 4,388 crore to Rs 15,327 crore and CarTrade Tech offering the largest market cap at Rs 15,327 crore. Each of these companies reported FY26 revenue between Rs 500 crore and Rs 1,000 crore, and net profit grew in FY26 and in the latest quarter.

This list covers companies with FY26 revenue between Rs 500 crore and Rs 1,000 crore, rising profit and complete, verifiable financials, ranked by market capitalisation. The companies here range from midcaps to largecaps in size. Investors screening stocks with Rs 500-1,000 crore revenue usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 20 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Stocks With Rs 500-1,000 Crore Revenue and Why Do They Attract Multibagger Interest?

Stocks with Rs 500-1,000 crore revenue are shares of companies whose annual sales in FY26 fell between Rs 500 crore and Rs 1,000 crore. The four here cover an online auto marketplace, diagnostics and two credit rating agencies.

Small revenue can still carry strong profit when margins are high, as these businesses show. For stocks with Rs 500-1,000 crore revenue, the margin and the profit trend matter more than size. Investors researching stocks with Rs 500-1,000 crore revenue get a fuller picture by reading growth and valuation together. The table below lines up stocks with Rs 500-1,000 crore revenue on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use stocks with Rs 500-1,000 crore revenue as a starting point for your own research.

Stocks With Rs 500-1,000 Crore Revenue at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 20 October 2026. ICRA has the lowest PE of the group at 22.36, while CARE Ratings posts the highest return on equity at 18.36%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
CarTrade Tech	3,032.90	15,327	60.54	64.49	8.98%	0.06	1,600.00 to 3,290.50
Vijaya Diagnostic Centre	1,368.20	14,228	75.90	60.75	18.07%	0.44	848.00 to 1,593.60
CARE Ratings	1,616.30	4,828	26.79	33.26	18.36%	0.03	1,392.70 to 1,838.00
ICRA	4,491.30	4,388	22.36	33.26	15.37%	0.02	4,198.20 to 6,620.00

CarTrade Tech: Revenue Up 22.27% in FY26

CarTrade Tech runs online marketplaces for new and used vehicles through platforms such as CarWale, CarTrade and Shriram Automall. It reported FY26 revenue of Rs 869.77 crore, up 22.27% year on year, and net profit of Rs 243.51 crore, up 67.63%. Revenue has compounded at 24.76% a year since FY22. Operating margin was 43.85% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

In the June 2026 quarter, revenue rose 15.74% to Rs 229.74 crore and net profit grew 20.59% to Rs 56.75 crore. The share price has gained 123.75% over five years and 18.74% over the past year. Domestic institutions raised their holding from 10.49% in June 2025 to 15.64% in June 2026. The stock trades at a PE of 60.54 against an industry PE of 64.49, below the sector average.

Vijaya Diagnostic: Quarterly Profit Up 37.60%

Vijaya Diagnostic Centre runs diagnostic centres offering pathology and radiology services, with a strong base in South India. It reported FY26 revenue of Rs 835 crore, up 19.34% year on year, and net profit of Rs 172.98 crore, up 20.30%. Net profit has compounded at 11.81% a year since FY22, while revenue has grown 15.13% a year. Operating margin was 43.94% in FY26. The debt-to-equity ratio is 0.44.

The stock trades at a PE of 75.90 against an industry PE of 60.75, with a return on equity of 18.07%. In the June 2026 quarter, revenue rose 22.76% to Rs 239.51 crore and net profit grew 37.60% to Rs 53.10 crore. The share price has gained 141.31% over five years and 38.44% over the past year. Domestic institutions raised their holding from 25.34% in September 2025 to 32.50% in September 2026.

CARE Ratings: 22.62% Profit CAGR Since FY22

CARE Ratings is a credit rating agency that rates debt instruments and bank facilities and also offers analytics and advisory services. It reported FY26 revenue of Rs 527.89 crore, up 16.51% year on year, and net profit of Rs 173.70 crore, up 24.07%. Net profit has compounded at 22.62% a year since FY22, while revenue has grown 17.73% a year. Operating margin was 53.32% in FY26. The debt-to-equity ratio is 0.03, which keeps interest costs low.

In the June 2026 quarter, revenue rose 17.54% to Rs 126.48 crore and net profit grew 24.49% to Rs 32.99 crore. The share price has gained 122.33% over five years. Domestic institutions raised their holding from 31.60% in September 2025 to 32.22% in September 2026. The stock trades at a PE of 26.79 against an industry PE of 33.26, below the sector average, with a return on equity of 18.36%.

ICRA: Debt-to-Equity of 0.02

ICRA is a credit rating and research company promoted by Moody's, and it also offers analytics, consulting and risk management services. It reported FY26 revenue of Rs 674.53 crore, up 17.22% year on year, and net profit of Rs 182.53 crore, up 6.62%. Net profit has compounded at 12.60% a year since FY22, while revenue has grown 15.15% a year. Operating margin was 47.23% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.

The stock trades at a PE of 22.36 against an industry PE of 33.26, below the sector average, with a return on equity of 15.37%. The dividend yield is 2.31%. In the June 2026 quarter, revenue rose 28.32% to Rs 191 crore and net profit grew 32.04% to Rs 56.46 crore. Foreign investors raised their holding from 6.87% in September 2025 to 8.00% in September 2026.

Stocks With Rs 500-1,000 Crore Revenue: Financial Comparison on Growth and Margins

The table compares scale and growth across these stocks with Rs 500-1,000 crore revenue. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Operating Margin (Latest Quarter)
CarTrade Tech	869.77	243.51	22.27%	24.76%	15.74%	43.98%
Vijaya Diagnostic	835	172.98	19.34%	15.13%	22.76%	46.35%
CARE Ratings	527.89	173.70	16.51%	17.73%	17.54%	44.26%
ICRA	674.53	182.53	17.22%	15.15%	28.32%	53.32%

Check the Univest Screener for live data on these stocks with Rs 500-1,000 crore revenue

Institutional Holding in CarTrade Tech, Vijaya Diagnostic, CARE Ratings and ICRA

Institutional holding shows who is backing these stocks with Rs 500-1,000 crore revenue alongside the promoter. The table uses the latest reported quarter for each. CarTrade Tech has the deepest institutional backing, with FII and DII together holding 70.01% as of June 2026. Domestic institutions increased their holding over the past year in CarTrade Tech (from 10.49% to 15.64%), Vijaya Diagnostic (from 25.34% to 32.50%) and CARE Ratings (from 31.60% to 32.22%).

Stock	Promoter	FII	DII	Public	Quarter
CarTrade Tech	Nil	54.37%	15.64%	29.99%	June 2026
Vijaya Diagnostic	52.46%	10.66%	32.50%	4.38%	September 2026
CARE Ratings	Nil	23.60%	32.22%	44.17%	September 2026
ICRA	51.87%	8.00%	20.12%	20.01%	September 2026

Risks to Weigh in Stocks With Rs 500-1,000 Crore Revenue

Being careful with stocks with Rs 500-1,000 crore revenue means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Vijaya Diagnostic trades at a PE of 75.90 against an industry PE of 60.75, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Stocks With Rs 500-1,000 Crore Revenue

Picking from stocks with Rs 500-1,000 crore revenue comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (33.26 to 64.49) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track CarTrade Tech, Vijaya Diagnostic, CARE Ratings and ICRA live prices.

Conclusion

Among stocks with Rs 500-1,000 crore revenue, CarTrade Tech stands out for the largest market cap at Rs 15,327 crore, Vijaya Diagnostic for the biggest five-year price gain at 141.31%, CARE Ratings for the highest return on equity at 18.36% and ICRA for the lowest PE of the group at 22.36. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks with Rs 500-1,000 crore revenue should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Stocks With Rs 500-1,000 Crore Revenue to Watch

Which are the best stocks with Rs 500-1,000 crore revenue to watch for multibagger potential?

Ans. CarTrade Tech, Vijaya Diagnostic, CARE Ratings and ICRA are the 4 names this list highlights, with market caps of Rs 15,327 crore, Rs 14,228 crore, Rs 4,828 crore and Rs 4,388 crore respectively. CarTrade Tech is notable for the largest market cap at Rs 15,327 crore. Vijaya Diagnostic stands out for the biggest five-year price gain at 141.31%. CARE Ratings offers the highest return on equity at 18.36%. ICRA brings the lowest PE of the group at 22.36. These are watchlist names for stocks with Rs 500-1,000 crore revenue, not recommendations, so match each one to your own risk profile and time horizon.

Is CARE Ratings a good stock for long-term investors?

Ans. CARE Ratings has a return on equity of 18.36%, a PE of 26.79 against an industry PE of 33.26 and a market cap of Rs 4,828 crore. Net profit has compounded at 22.62% a year since FY22, and FY26 revenue rose 16.51% while June 2026 quarter net profit grew 24.49%. Long-term returns in stocks with Rs 500-1,000 crore revenue depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can ICRA become a multibagger from here?

Ans. ICRA has a market cap of Rs 4,388 crore. A multibagger outcome in stocks with Rs 500-1,000 crore revenue requires earnings to keep growing faster than the market for several years. Net profit has compounded at 12.60% a year since FY22, and FY26 revenue rose 17.22%. At a PE of 22.36 against an industry PE of 33.26, valuation should be checked against that growth before investing.

What is the market cap of CarTrade Tech, Vijaya Diagnostic, CARE Ratings and ICRA?

Ans. As of 20 October 2026, CarTrade Tech has a market cap of Rs 15,327 crore, Vijaya Diagnostic has a market cap of Rs 14,228 crore, CARE Ratings has a market cap of Rs 4,828 crore and ICRA has a market cap of Rs 4,388 crore. CarTrade Tech is the largest of the group. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks with Rs 500-1,000 crore revenue.

What are the risks of investing in stocks with Rs 500-1,000 crore revenue?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Vijaya Diagnostic trades at a PE of 75.90 against an industry PE of 60.75, so earnings growth needs to hold up.

Why is Vijaya Diagnostic trading at a PE of 75.90?

Ans. Vijaya Diagnostic's PE of 75.90 compares with an industry PE of 60.75. The market is paying a premium for a return on equity of 18.07%, profit growth of 11.81% a year since FY22 and latest-quarter profit growth of 37.60%, which also means the stock is more sensitive if growth slows. Investors in stocks with Rs 500-1,000 crore revenue who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in CarTrade Tech, Vijaya Diagnostic, CARE Ratings and ICRA?

Ans. As of the latest reported quarter, FII and DII together hold 70.01% of CarTrade Tech (54.37% and 15.64%), 43.16% of Vijaya Diagnostic (10.66% and 32.50%), 55.82% of CARE Ratings (23.60% and 32.22%) and 28.12% of ICRA (8.00% and 20.12%). Rising institutional holding is a useful signal in stocks with Rs 500-1,000 crore revenue, though it should be read with earnings trends rather than on its own.